196 related articles for article (PubMed ID: 21900452)
1. Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance.
Bussolati B; Moggio A; Collino F; Aghemo G; D'Armento G; Grange C; Camussi G
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F116-28. PubMed ID: 21900452
[TBL] [Abstract][Full Text] [Related]
2. CD133+ renal progenitor cells contribute to tumor angiogenesis.
Bruno S; Bussolati B; Grange C; Collino F; Graziano ME; Ferrando U; Camussi G
Am J Pathol; 2006 Dec; 169(6):2223-35. PubMed ID: 17148683
[TBL] [Abstract][Full Text] [Related]
3. CD133+ cells as a therapeutic target for kidney diseases.
Bussolati B; Collino F; Camussi G
Expert Opin Ther Targets; 2012 Feb; 16(2):157-65. PubMed ID: 22324879
[TBL] [Abstract][Full Text] [Related]
4. Adult human CD133/1(+) kidney cells isolated from papilla integrate into developing kidney tubules.
Ward HH; Romero E; Welford A; Pickett G; Bacallao R; Gattone VH; Ness SA; Wandinger-Ness A; Roitbak T
Biochim Biophys Acta; 2011 Oct; 1812(10):1344-57. PubMed ID: 21255643
[TBL] [Abstract][Full Text] [Related]
5. Renal CD133(+)/CD73(+) progenitors produce erythropoietin under hypoxia and prolyl hydroxylase inhibition.
Bussolati B; Lauritano C; Moggio A; Collino F; Mazzone M; Camussi G
J Am Soc Nephrol; 2013 Jul; 24(8):1234-41. PubMed ID: 23661806
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
[TBL] [Abstract][Full Text] [Related]
7. Cystogenic potential of CD133+ progenitor cells of human polycystic kidneys.
Carvalhosa R; Deambrosis I; Carrera P; Pasquino C; Rigo F; Ferrari M; Lasaponara F; Ranghino A; Biancone L; Segoloni G; Bussolati B; Camussi G
J Pathol; 2011 Sep; 225(1):129-41. PubMed ID: 21706482
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2.
Iida H; Suzuki M; Goitsuka R; Ueno H
Int J Oncol; 2012 Jan; 40(1):71-9. PubMed ID: 21947321
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia improves expansion potential of human cord blood-derived hematopoietic stem cells and marrow repopulation efficiency.
Roy S; Tripathy M; Mathur N; Jain A; Mukhopadhyay A
Eur J Haematol; 2012 May; 88(5):396-405. PubMed ID: 22268587
[TBL] [Abstract][Full Text] [Related]
10. Plastic induction of CD133AC133-positive cells in the microenvironment of glioblastoma spheroids.
Ohnishi K; Tani T; Bando S; Kubota N; Fujii Y; Hatano O; Harada H
Int J Oncol; 2014 Aug; 45(2):581-6. PubMed ID: 24897999
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic/normoxic preconditioning increases endothelial differentiation potential of human bone marrow CD133+ cells.
Ong LL; Li W; Oldigs JK; Kaminski A; Gerstmayer B; Piechaczek C; Wagner W; Li RK; Ma N; Steinhoff G
Tissue Eng Part C Methods; 2010 Oct; 16(5):1069-81. PubMed ID: 20073989
[TBL] [Abstract][Full Text] [Related]
12. Analyzing migratory properties of human CD133(+) stem cells in vivo after intraoperative sternal bone marrow isolation.
Donndorf P; Useini D; Lux CA; Vollmar B; Delyagina E; Laupheimer M; Kaminski A; Steinhoff G
Cell Transplant; 2013; 22(9):1627-35. PubMed ID: 23051098
[TBL] [Abstract][Full Text] [Related]
13. Oct-4A isoform is expressed in human cord blood-derived CD133 stem cells and differentiated progeny.
Howe M; Zhao J; Bodenburg Y; McGuckin CP; Forraz N; Tilton RG; Urban RJ; Denner L
Cell Prolif; 2009 Jun; 42(3):265-75. PubMed ID: 19438894
[TBL] [Abstract][Full Text] [Related]
14. Only anti-CD133 antibodies recognizing the CD133/1 or the CD133/2 epitopes can identify human renal progenitors.
Angelotti ML; Lazzeri E; Lasagni L; Romagnani P
Kidney Int; 2010 Sep; 78(6):620-1; author reply 621. PubMed ID: 20805819
[No Abstract] [Full Text] [Related]
15. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys.
Sagrinati C; Netti GS; Mazzinghi B; Lazzeri E; Liotta F; Frosali F; Ronconi E; Meini C; Gacci M; Squecco R; Carini M; Gesualdo L; Francini F; Maggi E; Annunziato F; Lasagni L; Serio M; Romagnani S; Romagnani P
J Am Soc Nephrol; 2006 Sep; 17(9):2443-56. PubMed ID: 16885410
[TBL] [Abstract][Full Text] [Related]
17. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation.
Kemper K; Sprick MR; de Bree M; Scopelliti A; Vermeulen L; Hoek M; Zeilstra J; Pals ST; Mehmet H; Stassi G; Medema JP
Cancer Res; 2010 Jan; 70(2):719-29. PubMed ID: 20068153
[TBL] [Abstract][Full Text] [Related]
18. Isolation of renal progenitor cells from adult human kidney.
Bussolati B; Bruno S; Grange C; Buttiglieri S; Deregibus MC; Cantino D; Camussi G
Am J Pathol; 2005 Feb; 166(2):545-55. PubMed ID: 15681837
[TBL] [Abstract][Full Text] [Related]
19. Perfluorocarbon solutions limit tubular epithelial cell injury and promote CD133+ kidney progenitor differentiation: potential use in renal assist devices for sepsis-associated acute kidney injury and multiple organ failure.
Cantaluppi V; Medica D; Quercia AD; Dellepiane S; Figliolini F; Virzì GM; Brocca A; Quaglia M; Marengo M; Olivieri C; Senzolo M; Garzotto F; Della Corte F; Castellano G; Gesualdo L; Camussi G; Ronco C
Nephrol Dial Transplant; 2018 Jul; 33(7):1110-1121. PubMed ID: 29267971
[TBL] [Abstract][Full Text] [Related]
20. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.
Chen Q; Khoury M; Limmon G; Choolani M; Chan JK; Chen J
Stem Cells; 2013 Jun; 31(6):1160-9. PubMed ID: 23404852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
